Indication · Radiology & Imaging
Tumor ablation
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
81
Cleared or approved since 2000
PMA and De Novo
4
Higher-risk or first-of-kind devices
Breakthrough devices
1
Authorized through June 30, 2026
Recruiting device trials
45
235 device trials in all
Breakthrough-designated devices
- Edison SystemHistoSonics, Inc. · 2024
Devices
77 devices via 510(k). PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- NanoKnife Generator (H78720300351US0)
Angiodynamics · 510(k) · Low Energy Direct Current Thermal Ablation System · newest 2026 · 5 decisions
59 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
Northwell HealthAcademic, hospital or other
NCT04656678 · 200 participants (planned) · Start Nov 25, 2020 · Primary completion Oct 30, 2028
Device: Cryo-ablation Using DynaCAD / UroNAV preplanning / guidance · For: Prostate Cancer; Prostate Disease; Locally Recurrent Prostate Cancer
Sites: Lake Success, New York; New York, New York · 3 sites in all
234 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- System, Ablation, Microwave And Accessories (NEY)53
- Low Energy Direct Current Thermal Ablation System (OAB)10
- Radiological Image Processing Software For Ablation Therapy Planning And Evaluation (QTZ)7
- System, Ablation, Ultrasound And Accessories (NTB)6
- Post-Ablation Tissue Response Prediction Software (QZL)2
- System, Rf/Microwave Hyperthermia, Cancer Treatment (LOC)1
- Ultrasound, Hyperthermia, Cancer Treatment (LSY)1
- Focused Ultrasound System For Non-Thermal, Mechanical Tissue Ablation (QGM)1
Research
- Device studies on tumor ablation across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.